{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T07:27:21Z","timestamp":1773991641607,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY022936"],"award-info":[{"award-number":["EY022936"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS072141"],"award-info":[{"award-number":["NS072141"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS25304"],"award-info":[{"award-number":["NS25304"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008087","name":"Guthy-Jackson Charitable Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008087","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI110498"],"award-info":[{"award-number":["UM1AI110498"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12974-016-0767-4","type":"journal-article","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T12:11:06Z","timestamp":1480594266000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica"],"prefix":"10.1186","volume":"13","author":[{"given":"Yiting","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle E.","family":"Harlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine S.","family":"Given","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory P.","family":"Owens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy B.","family":"Macklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey L.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,1]]},"reference":[{"key":"767_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrneurol.2014.141","volume":"10","author":"MC Papadopoulos","year":"2014","unstructured":"Papadopoulos MC, Bennett JL, Verkman AS. Treatment of neuromyelitis optica: state-of-the-art and emerging therapies. Nat Rev Neurol. 2014;10:493\u2013506.","journal-title":"Nat Rev Neurol"},{"key":"767_CR2","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.4049\/jimmunol.1203200","volume":"190","author":"D Ricklin","year":"2013","unstructured":"Ricklin D, Lambris JD. Complement in immune and inflammatory disorders: therapeutic interventions. J Immunol. 2013;190:3839\u201347.","journal-title":"J Immunol"},{"key":"767_CR3","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1523\/JNEUROSCI.3932-10.2011","volume":"31","author":"ME Benoit","year":"2011","unstructured":"Benoit ME, Tenner AJ. Complement protein C1q-mediated neuroprotection is correlated with regulation of neuronal gene and microRNA expression. J Neurosci. 2011;31:3459\u201369.","journal-title":"J Neurosci"},{"key":"767_CR4","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1523\/JNEUROSCI.4473-12.2015","volume":"35","author":"SL Peterson","year":"2015","unstructured":"Peterson SL, Nguyen HX, Mendez OA, Anderson AJ. Complement protein C1q modulates neurite outgrowth in vitro and spinal cord axon regeneration in vivo. J Neurosci. 2015;35:4332\u201349.","journal-title":"J Neurosci"},{"key":"767_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev-neuro-061010-113810","volume":"35","author":"AH Stephan","year":"2012","unstructured":"Stephan AH, Barres BA, Stevens B. The complement system: an unexpected role in synaptic pruning during development and disease. Annu Rev Neurosci. 2012;35:369\u201389.","journal-title":"Annu Rev Neurosci"},{"key":"767_CR6","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3389\/fncel.2014.00380","volume":"8","author":"F Orsini","year":"2014","unstructured":"Orsini F, De Blasio D, Zangari R, Zanier ER, De Simoni MG. Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis. Front Cell Neurosci. 2014;8:380.","journal-title":"Front Cell Neurosci"},{"key":"767_CR7","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/brain\/awl371","volume":"130","author":"SF Roemer","year":"2007","unstructured":"Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain. 2007;130:1194\u2013205.","journal-title":"Brain"},{"key":"767_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ana.23621","volume":"72","author":"W Bruck","year":"2012","unstructured":"Bruck W, Popescu B, Lucchinetti CF, Markovic-Plese S, Gold R, Thal DR, Metz I. Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate. Ann Neurol. 2012;72:385\u201394.","journal-title":"Ann Neurol"},{"key":"767_CR9","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jneuroim.2012.09.002","volume":"254","author":"H Kuroda","year":"2013","unstructured":"Kuroda H, Fujihara K, Takano R, Takai Y, Takahashi T, Misu T, Nakashima I, Sato S, Itoyama Y, Aoki M. Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica. J Neuroimmunol. 2013;254:178\u201382.","journal-title":"J Neuroimmunol"},{"key":"767_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jneuroim.2014.07.001","volume":"274","author":"P Nytrova","year":"2014","unstructured":"Nytrova P, Potlukova E, Kemlink D, Woodhall M, Horakova D, Waters P, Havrdova E, Zivorova D, Vincent A, Trendelenburg M. Complement activation in patients with neuromyelitis optica. J Neuroimmunol. 2014;274:185\u201391.","journal-title":"J Neuroimmunol"},{"key":"767_CR11","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005;202:473\u20137.","journal-title":"J Exp Med"},{"key":"767_CR12","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/ana.21802","volume":"66","author":"JL Bennett","year":"2009","unstructured":"Bennett JL, Lam C, Kalluri SR, Saikali P, Bautista K, Dupree C, Glogowska M, Case D, Antel JP, Owens GP, et al. Intrathecal pathogenic anti\u2013aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol. 2009;66:617\u201329.","journal-title":"Ann Neurol"},{"key":"767_CR13","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/ana.22551","volume":"70","author":"H Zhang","year":"2011","unstructured":"Zhang H, Bennett JL, Verkman AS. Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms. Ann Neurol. 2011;70:943\u201354.","journal-title":"Ann Neurol"},{"key":"767_CR14","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/ana.21837","volume":"66","author":"M Bradl","year":"2009","unstructured":"Bradl M, Misu T, Takahashi T, Watanabe M, Mader S, Reindl M, Adzemovic M, Bauer J, Berger T, Fujihara K, et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol. 2009;66:630\u201343.","journal-title":"Ann Neurol"},{"key":"767_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.bbrc.2010.02.157","volume":"394","author":"M Kinoshita","year":"2010","unstructured":"Kinoshita M, Nakatsuji Y, Kimura T, Moriya M, Takata K, Okuno T, Kumanogoh A, Kajiyama K, Yoshikawa H, Sakoda S. Anti-aquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cells. Biochem Biophys Res Commun. 2010;394:205\u201310.","journal-title":"Biochem Biophys Res Commun"},{"key":"767_CR16","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00401-013-1128-3","volume":"125","author":"PW Phuan","year":"2013","unstructured":"Phuan PW, Zhang H, Asavapanumas N, Leviten M, Rosenthal A, Tradtrantip L, Verkman AS. C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica. Acta Neuropathol. 2013;125:829\u201340.","journal-title":"Acta Neuropathol"},{"key":"767_CR17","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s12264-015-1552-6","volume":"31","author":"M Li","year":"2015","unstructured":"Li M, Yan Y. Experimental models of neuromyelitis optica: current status, challenges and future directions. Neurosci Bull. 2015;31:735\u201344.","journal-title":"Neurosci Bull"},{"key":"767_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s002620000120","volume":"49","author":"I Bergman","year":"2000","unstructured":"Bergman I, Basse PH, Barmada MA, Griffin JA, Cheung NK. Comparison of in vitro antibody-targeted cytotoxicity using mouse, rat and human effectors. Cancer Immunol Immunother. 2000;49:259\u201366.","journal-title":"Cancer Immunol Immunother"},{"key":"767_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.molimm.2014.06.003","volume":"62","author":"J Ratelade","year":"2014","unstructured":"Ratelade J, Verkman AS. Inhibitor(s) of the classical complement pathway in mouse serum limit the utility of mice as experimental models of neuromyelitis optica. Mol Immunol. 2014;62:104\u201313.","journal-title":"Mol Immunol"},{"key":"767_CR20","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1523\/JNEUROSCI.22-03-00876.2002","volume":"22","author":"BS Mallon","year":"2002","unstructured":"Mallon BS, Shick HE, Kidd GJ, Macklin WB. Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development. J Neurosci. 2002;22:876\u201385.","journal-title":"J Neurosci"},{"key":"767_CR21","doi-asserted-by":"publisher","first-page":"6561","DOI":"10.1074\/jbc.M708096200","volume":"283","author":"Y Liu","year":"2008","unstructured":"Liu Y, Vidensky S, Ruggiero AM, Maier S, Sitte HH, Rothstein JD. Reticulon RTN2B regulates trafficking and function of neuronal glutamate transporter EAAC1. J Biol Chem. 2008;283:6561\u201371.","journal-title":"J Biol Chem"},{"key":"767_CR22","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1083\/jcb.85.3.890","volume":"85","author":"KD McCarthy","year":"1980","unstructured":"McCarthy KD, de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol. 1980;85:890\u2013902.","journal-title":"J Cell Biol"},{"key":"767_CR23","doi-asserted-by":"publisher","first-page":"12018","DOI":"10.1523\/JNEUROSCI.5151-14.2015","volume":"35","author":"DE Harlow","year":"2015","unstructured":"Harlow DE, Saul KE, Komuro H, Macklin WB. Myelin proteolipid protein complexes with alphav integrin and AMPA receptors in vivo and regulates AMPA-dependent oligodendrocyte progenitor cell migration through the modulation of cell-surface GluR2 expression. J Neurosci. 2015;35:12018\u201332.","journal-title":"J Neurosci"},{"key":"767_CR24","doi-asserted-by":"crossref","first-page":"7398","DOI":"10.1523\/JNEUROSCI.22-17-07398.2002","volume":"22","author":"TI Gudz","year":"2002","unstructured":"Gudz TI, Schneider TE, Haas TA, Macklin WB. Myelin proteolipid protein forms a complex with integrins and may participate in integrin receptor signaling in oligodendrocytes. J Neurosci. 2002;22:7398\u2013407.","journal-title":"J Neurosci"},{"key":"767_CR25","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/glia.22272","volume":"60","author":"GK Sheridan","year":"2012","unstructured":"Sheridan GK, Dev KK. S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures. Glia. 2012;60:382\u201392.","journal-title":"Glia"},{"key":"767_CR26","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1083\/jcb.145.6.1209","volume":"145","author":"DJ Osterhout","year":"1999","unstructured":"Osterhout DJ, Wolven A, Wolf RM, Resh MD, Chao MV. Morphological differentiation of oligodendrocytes requires activation of Fyn tyrosine kinase. J Cell Biol. 1999;145:1209\u201318.","journal-title":"J Cell Biol"},{"key":"767_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.cell.2009.04.031","volume":"138","author":"B Emery","year":"2009","unstructured":"Emery B, Agalliu D, Cahoy JD, Watkins TA, Dugas JC, Mulinyawe SB, Ibrahim A, Ligon KL, Rowitch DH, Barres BA. Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination. Cell. 2009;138:172\u201385.","journal-title":"Cell"},{"key":"767_CR28","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/WNO.0000000000000102","volume":"34","author":"MC Kowarik","year":"2014","unstructured":"Kowarik MC, Soltys J, Bennett JL. The treatment of neuromyelitis optica. J Neuroophthalmol. 2014;34:70\u201382.","journal-title":"J Neuroophthalmol"},{"key":"767_CR29","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1016\/j.molimm.2011.04.003","volume":"48","author":"R Veerhuis","year":"2011","unstructured":"Veerhuis R, Nielsen HM, Tenner AJ. Complement in the brain. Mol Immunol. 2011;48:1592\u2013603.","journal-title":"Mol Immunol"},{"key":"767_CR30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/brain\/awp309","volume":"133","author":"S Saadoun","year":"2010","unstructured":"Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, Papadopoulos MC. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain. 2010;133:349\u201361.","journal-title":"Brain"},{"key":"767_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.molimm.2004.07.043","volume":"42","author":"JM Thurman","year":"2005","unstructured":"Thurman JM, Kraus DM, Girardi G, Hourcade D, Kang HJ, Royer PA, Mitchell LM, Giclas PC, Salmon J, Gilkeson G, Holers VM. A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice. Mol Immunol. 2005;42:87\u201397.","journal-title":"Mol Immunol"},{"key":"767_CR32","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1523\/JNEUROSCI.4178-07.2008","volume":"28","author":"JD Cahoy","year":"2008","unstructured":"Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS, Xing Y, Lubischer JL, Krieg PA, Krupenko SA, et al. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci. 2008;28:264\u201378.","journal-title":"J Neurosci"},{"key":"767_CR33","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.4049\/jimmunol.166.6.4154","volume":"166","author":"SA O\u2019Barr","year":"2001","unstructured":"O\u2019Barr SA, Caguioa J, Gruol D, Perkins G, Ember JA, Hugli T, Cooper NR. Neuronal expression of a functional receptor for the C5a complement activation fragment. J Immunol. 2001;166:4154\u201362.","journal-title":"J Immunol"},{"key":"767_CR34","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/ana.20182","volume":"56","author":"CF Lucchinetti","year":"2004","unstructured":"Lucchinetti CF, Bruck W, Lassmann H. Evidence for pathogenic heterogeneity in multiple sclerosis. Ann Neurol. 2004;56:308.","journal-title":"Ann Neurol"},{"key":"767_CR35","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00401-013-1116-7","volume":"125","author":"T Misu","year":"2013","unstructured":"Misu T, Hoftberger R, Fujihara K, Wimmer I, Takai Y, Nishiyama S, Nakashima I, Konno H, Bradl M, Garzuly F, et al. Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica. Acta Neuropathol. 2013;125:815\u201327.","journal-title":"Acta Neuropathol"},{"key":"767_CR36","doi-asserted-by":"publisher","first-page":"9025","DOI":"10.1073\/pnas.86.22.9025","volume":"86","author":"DR Wren","year":"1989","unstructured":"Wren DR, Noble M. Oligodendrocytes and oligodendrocyte\/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody. Proc Natl Acad Sci U S A. 1989;86:9025\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"767_CR37","first-page":"140","volume":"76","author":"MG Wing","year":"1992","unstructured":"Wing MG, Zajicek J, Seilly DJ, Compston DA, Lachmann PJ. Oligodendrocytes lack glycolipid anchored proteins which protect them against complement lysis. Restoration of resistance to lysis by incorporation of CD59. Immunology. 1992;76:140\u20135.","journal-title":"Immunology"},{"key":"767_CR38","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0165-5728(93)90189-6","volume":"48","author":"SJ Piddlesden","year":"1993","unstructured":"Piddlesden SJ, Morgan BP. Killing of rat glial cells by complement: deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis. J Neuroimmunol. 1993;48:169\u201375.","journal-title":"J Neuroimmunol"},{"key":"767_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0165-5728(97)00241-5","volume":"84","author":"NJ Scolding","year":"1998","unstructured":"Scolding NJ, Morgan BP, Compston DA. The expression of complement regulatory proteins by adult human oligodendrocytes. J Neuroimmunol. 1998;84:69\u201375.","journal-title":"J Neuroimmunol"},{"key":"767_CR40","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1097\/00001756-199803300-00030","volume":"9","author":"C Agoropoulou","year":"1998","unstructured":"Agoropoulou C, Piddlesden SJ, Lachmann PJ, Wing MG. Neuronal protection of oligodendrocytes from antibody-independent complement lysis. Neuroreport. 1998;9:927\u201332.","journal-title":"Neuroreport"},{"key":"767_CR41","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00401-013-1220-8","volume":"127","author":"C Wrzos","year":"2014","unstructured":"Wrzos C, Winkler A, Metz I, Kayser DM, Thal DR, Wegner C, Bruck W, Nessler S, Bennett JL, Stadelmann C. Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions. Acta Neuropathol. 2014;127:523\u201338.","journal-title":"Acta Neuropathol"},{"key":"767_CR42","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/ana.20016","volume":"55","author":"MH Barnett","year":"2004","unstructured":"Barnett MH, Prineas JW. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol. 2004;55:458\u201368.","journal-title":"Ann Neurol"},{"key":"767_CR43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1523\/JNEUROSCI.22-02-00455.2002","volume":"22","author":"SA Back","year":"2002","unstructured":"Back SA, Han BH, Luo NL, Chricton CA, Xanthoudakis S, Tam J, Arvin KL, Holtzman DM. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci. 2002;22:455\u201363.","journal-title":"J Neurosci"},{"key":"767_CR44","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/nn.3357","volume":"16","author":"SH Kang","year":"2013","unstructured":"Kang SH, Li Y, Fukaya M, Lorenzini I, Cleveland DW, Ostrow LW, Rothstein JD, Bergles DE. Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat Neurosci. 2013;16:571\u20139.","journal-title":"Nat Neurosci"},{"key":"767_CR45","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.bbrc.2009.06.085","volume":"386","author":"M Kinoshita","year":"2009","unstructured":"Kinoshita M, Nakatsuji Y, Kimura T, Moriya M, Takata K, Okuno T, Kumanogoh A, Kajiyama K, Yoshikawa H, Sakoda S. Neuromyelitis optica: passive transfer to rats by human immunoglobulin. Biochem Biophys Res Commun. 2009;386:623\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"767_CR46","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1742-2094-11-16","volume":"11","author":"N Asavapanumas","year":"2014","unstructured":"Asavapanumas N, Ratelade J, Papadopoulos MC, Bennett JL, Levin MH, Verkman AS. Experimental mouse model of optic neuritis with inflammatory demyelination produced by passive transfer of neuromyelitis optica-immunoglobulin G. J Neuroinflammation. 2014;11:16.","journal-title":"J Neuroinflammation"},{"key":"767_CR47","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jaut.2014.02.011","volume":"53","author":"H Zhang","year":"2014","unstructured":"Zhang H, Verkman AS. Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59. J Autoimmun. 2014;53:67\u201377.","journal-title":"J Autoimmun"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-016-0767-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-016-0767-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-016-0767-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T07:13:10Z","timestamp":1589526790000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-016-0767-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["767"],"URL":"https:\/\/doi.org\/10.1186\/s12974-016-0767-4","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"16 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"301"}}